Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Treatment for Brain Insulin Resistance and Hypoperfusion

NCT05153395 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT05153395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05153395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Treatment for Brain Insulin Resistance and Hypoperfusion
Lead sponsor
University of Missouri-Columbia
Phase
Phase 1
Overall status
Suspended
Start date
December 1, 2021
Completion date
June 30, 2027
Enrollment
65 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autonomic dysfunction, healthy, insulin resistance, obesity, vasodilation